 The report established that the analysis for the trial had been carried out by Procter & Gamble and that Eastell did not in fact have complete access to the data.Eastell wrote a letter in 2007 to the editors of the "Journal of Bone and Mineral Research", where the paper in question was published in 2003, accepting that he had not disclosed limitations on data access as required by the journal and acknowledging certain errors in the paper.At a General Medical Council "fitness to practice" hearing in November 2009, it was determined that Eastell's actions had not been "deliberately misleading or dishonest", although he may have been negligent in making "untrue" and "misleading" declarations; the council did not make a finding of misconduct.